The Library

DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with Ulcerative Colitis (UC)

Tools

Arasaradnam, Ramesh P., Khoo, K. T. J., Bradburn, Mike, Mathers, John C. and Kelly, S. B.. (2010) DNA methylation of ESR-1 and N-33 in colorectal mucosa of patients with Ulcerative Colitis (UC). Epigenetics, Vol.5 (No.5). pp. 422-426. ISSN 1559-2294

PDF
WRAP_Arasaradnam_Revised_Manuscript_Epigenetics_2010EPI0026_(3).pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (142Kb)

Official URL: http://www.landesbioscience.com/journals/7/article...

Abstract

Introduction: Epigenetic marking such as DNA methylation influence gene transcription and chromosomal stability and may also be affected by environmental exposures. Few studies exist on alteration in DNA methylation profiles (genomic and gene specific methylation) in patients with Ulcerative Colitis (UC) and none assessing its relationship with lifestyle exposures. Aims & Methods: To assess genomic methylation and promoter methylation of the ESR-1 (oestrogen receptor - 1) and N-33 (tumour suppressor candidate-3) genes in the macroscopically normal mucosa of UC patients as well as to investigate effects of anthropometric and lifestyle exposures on DNA methylation. Sixty eight subjects were recruited (24 UC and 44 age and sex matched controls). Colorectal mucosal biopsies were obtained and DNA was extracted. Genomic DNA methylation was quantified using the tritium-labelled cytosine extension assay (3[H] dCTP) whilst gene specific methylation was quantified using the COBRA method. Results: The methylation level of both ESR-1 and N-33 genes were significantly higher in UC subjects compared with controls (7.9% vs 5.9%; p = 0.015 and 66% vs 9.3%; p < 0.001 respectively). There was no detectable difference in global DNA methylation between patients with UC and age and sex matched controls. No associations between indices of DNA methylation and anthropometric measures or smoking patterns were detected. Conclusions: For the first time, we have shown increased methylation in the promoter regions of the putative tumour suppressor gene N-33 in macroscopically normal mucosa of patients with UC. In addition, we have confirmed that methylation of ESR-1 promoter is higher in UC patients compared with age and sex matched controls. These findings suggests that, inactivation through methylation of the putative tumour suppressor genes N-33 and ESR-1, may not be associated with colorectal carcinogenesis in UC.

Item Type:	Journal Article
Alternative Title:	DNA methylation of ESR-1 and N-33 in Ulcerative Colitis
Subjects:	Q Science > QP Physiology R Medicine > RC Internal medicine
Divisions:	Faculty of Medicine > Warwick Medical School > Clinical Sciences Research Institute (CSRI) Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	DNA -- Methylation, Antioncogenes, Ulcerative colitis, Gastrointestinal mucosa
Journal or Publication Title:	Epigenetics
Publisher:	Landes Bioscience
ISSN:	1559-2294
Date:	1 July 2010
Volume:	Vol.5
Number:	No.5
Page Range:	pp. 422-426
Status:	Peer Reviewed
Access rights to Published version:	Open Access
Funder:	Great Britain. Food Standards Agency (FSA), Ileostomy Association of Great Britain and Ireland
Grant number:	N12105 (FSA)
References:	1. Bird AP. The relationship of DNA methylation to cancer. Cancer Surv 1996;28: 87-101. 2. Bird AP. and Wolffe AP. Methylation-Induced Repression - Belts, Braces, and Chromatin. Cell 1999; 99(5): 451-454. 3. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005; 6(8): 597-610. 4. Hendrich B and Bird A. Mammalian methyltransferases and methyl-CpG-binding domains: proteins involved in DNA methylation. Curr Top Microbiol Immunol 2000;249: 55-74. 5. Wilson AS, Power BE and Molloy PL. DNA hypomethylation and human diseases. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2007; 1775(1): 138-162. 6. Costello, JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet 2000; 24(2): 132-138. 7. Agrawal A, Murphy RF and Agrawal DK. DNA methylation in breast and colorectal cancers. Mod Pathol 2007; 20(7): 711-21. 8. Jones PA. DNA Methylation Errors and Cancer. Cancer Res 1996; 56(11): 2463-2467. 9. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1(7): 686-92. 10. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998; 58(23): 5489-94. 11. Issa JP., Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon." Nat Genet 1994; 7(4): 536-40. 12. Issa JP. Ahuja N, Toyota M, Bronne MP, Brentnall JA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61(9): 3573-3577. 13. Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa A, Tomita S et al. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in non-neoplastic epithelium from patients with ulcerative colitis. Clin Cancer Res 2005; 11(24): 8880-8885. 14. Walmsley RS, Ayres RCS, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43(1): 29-32. 15. Pogribny I, Yi P, James SJ. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochemical and Biophysical Research Communications 1999; 262(3): 624-628. 16. Xiong Z. and Laird P. COBRA: a sensitive and quantitative DNA methylation assay. Nucl. Acids Res. 1997; 25(12): 2532-2534. 17. Crohn BB, Ginzburg L, Oppenheimer G D. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. JAMA 1984; 251(1): 73-9. 18. Ransohoff DF. Colon cancer in ulcerative colitis. Gastroenterology 1988; 94(4): 1089-91. 19. Ekbom A, Helmick C, Zack M and Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990; 323(18): 1228-33. 20. Gloria L, Cravo M, Pinto A, de Sousa LS, Cahves P, Leitao CN et al. DNA hypomethylation and proliferative activity are increased in the rectal mucosa of patients with long-standing ulcerative colitis. Cancer 1996; 78(11): 2300-6. 21. Tahara T, Inoue N, Hisamatsu T, Kashiwagi K,Takaishi H, Kanai T et al. Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis. Journal of Gastroenterology and Hepatology 2005; 20(5): 710-715. 22. Fujii S, Tominaga K, Kitajima K, Takeda J, Kusaka T, Fujita M et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005; 54(9): 1287-1292. 23. Pufulete M, Al-Ghnaniem R, Rennie JA, Appleby P, Harris N, Gout S et al. Influence of folate status on genomic DNA methylation in colonic mucosa of subjects without colorectal adenoma or cancer. Br J Cancer 2005; 92(5): 838-42. 24. Risques RA, Lai LA, Brentall TA, Li L, Feng A, Gallaher J et al. Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 2008;135(2):410-8 25. Arasaradnam RP, Commane D, Bradburn M and Mathers JC. A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 2008; 3(4): 193-8.
URI:	http://wrap.warwick.ac.uk/id/eprint/3198